Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-03 · accession 0001493152-24-015789 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-24 | 2024-04-03 | BIAF | GIRGENTI STEVEN | Dir | M - OptEx | $1.16 | +64.8K | 1.06M | +7% | +$75.2K |
| D | 2024-04-24 | 2024-04-03 | BIAF | GIRGENTI STEVEN | Dir | F - Tax | $2.24 | -33.4K | 1.02M | -3% | -$74.9K |
| D | 2024-04-24 | 2024-04-03 | BIAF | GIRGENTI STEVEN | Dir | M - OptEx | $0.00 | -64.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-03 | M | A | 64,848 | $1.16 | 1,056,606 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-03 | F | D | 33,438 | $2.24 | 1,023,168 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-04-03 | M | D | 64,848 | $0.00 | 0 | D | $1.16 · — to 2024-04-28 | 64,848 Common Stock | (F3) This option vested in 7 equal monthly installments beginning on April 28, 2014. |